Clinical Trials Directory

Trials / Completed

CompletedNCT03074123

Cortisol Response to Low Dose Cosyntropin Stimulation Test in the Late Afternoon

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Bnai Zion Medical Center · Other Government
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Previous study showed that afternoon cosyntropin testing was associated with a sevenfold increased likelihood of failing the 1μg test. However, in that study, investigators used a 20.3 cm plastic tube, which might have led to uncompleted cosyntropin delivery. In ther current study investigators will study afternoon 1μg cosyntropin cortisol stimulation using a short 2.5 cm tube.

Detailed description

In earlier studies investigators claimed that subnormal cortisol response using plastic tubes might result from cosyntropin adherence to the tube and loss of the delivered dosage. It was shown that 21.6-58.6% of ACTH dosage had not been recovered when pushed through 20.3 cm plastic tube, and loss of ACTH may be up to 70% when cosyntropin was delivered through a plastic 30 cm scalp vein set. Moreover, it was previously shown that afternoon cosyntropin testing was associated with a sevenfold increased likelihood of failing the 1μg test. However, in that study, investigators used a 20.3 cm plastic tube, which might have led to uncompleted cosyntropin delivery. In ther current study investigators will study afternoon 1μg cosyntropin cortisol stimulation using a short 2.5 cm tube.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTlow-dose cosyntropin stimulation testEach subject recruited in the study will undergo low dose cosyntropin stimulation test via intravenous short 2.5 cm plastic tube. 1 μg/ml ACTH aliquot stock solution will be pushed through, followed by 5 ml physiologic saline (0.9%). For each subject, serum and salivary cortisol will be measured just before cosyntropin administration and 30 minutes later.

Timeline

Start date
2017-04-01
Primary completion
2018-08-01
Completion
2018-08-01
First posted
2017-03-08
Last updated
2019-01-18

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT03074123. Inclusion in this directory is not an endorsement.